Location & dates EMBL Heidelberg, Germany 28 - 30 Apr 2021 Register interest
Deadlines Registration will open shortly
organiser_EMBO_Workshop_2017

Coronavirus information for participants

The onsite course and conference programme at EMBL has been paused until the end of June 2020.


We aim to continue offering our advanced training for the scientific community however we safely can. While some events have been cancelled, many have been rescheduled for a later date and others will be delivered as virtual events.


Registration is open for onsite courses and conferences starting after 1 July and for the virtual events. All registration fees for any events which don’t take place due to the COVID-19 disruption are fully refundable.


More information for participants of events at EMBL Heidelberg can be found here.

Registration is not yet open for this event. If you are interested in receiving more information please register your interest.

Conference Overview

The regulation of the transcriptome is key to cellular processes that underpin cell biology, development and tissue function. All classes of cellular RNA are subject to post-transcriptional modification, be it by direct chemical modification, editing or non-templated nucleotide additions. It is now emerging that the modification status of the transcriptome is dynamic and responsive to environmental/developmental cues. Together, this has elicited the realisation of an ‘epitranscriptome’ where post-transcriptional RNA modification coupled with recruitment of effector RNA binding proteins dynamically regulates genomic output. Importantly, mutations in setting or reading RNA modifications are causative of many human diseases or congenital disorders. This meeting aims to explore all aspects of this emerging topic, from methods development to molecular mechanism. Most importantly, the meeting will place an emphasis on the contribution of RNA modification to mammalian development, tissue homeostasis and disease.

Session Topics

  • RNA modification I (m6A)
  • RNA modifications in stem cells and development
  • RNA modification II (m5C, m1A, 3’ terminal additions, etc)
  • RNA modification pathways in physiology and pathology
  • Emerging concepts

What past participants say about the conference:

“The Epitranscriptome EMBL conference rapidly became a must in the field.” - Mattia Pelizzola, Istituto Italiano di Tecnologia, Italy.

"The conference provided an excellent opportunity to get the latest insights in the field of epitranscriptomics, presented by the world-leading academic groups." - Gerhard Müller, Gotham Therapeutics, New York, USA.

"This conference was really good for me. I have learnt about new RNA regulatory mechanisms, especially m6A and how it's an important target for RNA processing." - Opeyemi Olotu, University of Turku, Finland.

 

EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme

Founder partners

  • Leica logo
  • Olympus logo

Corporate partners

  • 10x Genomics_120x82
  • Becton Dickinson logo
  • Bio-Rad logo
  • Boehringer Ingelheim logo
  • Eppendorf logo
  • GSK logo
  • Milteniy Biotec logo
  • Stilla logo
  • ThermoFisher logo

Associate partners

  • Merck logo
  • New England Biolabs logo
  • Nikon logo
  • Promega logo
  • Roche logo
  • Sanofi logo
  • Sartorius logo